Innovent Biologics Technology Limited (shanghai R&d Center)

This early-phase trial tests a new drug called IBI3026 in about 300 adults with advanced solid tumors that cannot be removed by surgery or have spread. The main goals are to find the safest dose and check for side effects. Researchers will also watch if the drug helps shrink tumo…